Search results
Showing 451 to 500 of 8137 results
Admission to hospital and delayed discharge can affect people's mental and physical wellbeing and make them increasingly dependent on support services
We support the involvement of people who use services, carers, members of the public and organisations who represent their interests across NICE. Our
How voluntary and community sector (VCS) organisations can help us develop guidance
Support for organisations who contribute to developing our guidance
Find out how we assess the value of digital health technologies and help developers build the evidence needed to achieve market access and improve lives.
These resources are for users in England only. Find out more about our eligibility criteria . If you work somewhere else in the UK, you can still...
Tailored content for our communities: Medicines and prescribing, general practice, social care, the public, library and knowledge services and local government.
Digital services to enable easier access to weight management support
Four digital programmes can be used to help the NHS deliver specialist weight management services to support the use of medication in England, NICE has said in draft guidance.
Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease (TA912)
Evidence-based recommendations on cipaglucosidase alfa (Pombiliti) with miglustat (Opfolda) for treating late-onset Pompe disease in adults.
Information about transport layer security (TLS) 1.2 upgrade
Andy Tilden, interim CEO at Skills for Care May 2019 What this report reinforces is Skills for Care's view that a skilled and knowledgeable
Artificial intelligence technologies to speed up contouring in radiotherapy treatment planning
Nine artificial intelligence technologies can be used to help plan the treatment of those undergoing external beam radiotherapy for cancers such as lung, prostate or colorectal, NICE has said in draft guidance.
Early value assessment (EVA) guidance on the Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies...
Evidence-based recommendations on aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease in adults. This involves replacing the diseased part of the valve with some of the person’s own pericardium.
View recommendations for IPG769Show all sections
Consultation on changes to technology appraisals and highly specialised technologies
NICE and NHS England have launched a 12 week consultation on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programmes.
These are the main stages in developing diagnostic technologies guidance. Timings are approximate. For a full description of the process see the:...
Who can become a registered stakeholder? Registration is open to anyone with an interest in the topic who is one of the following: The company that
How NICE manages the potential conflicts of interests of patient experts
People with lived experience provide valuable insight into the impact of NICE’s’ guidance and advice.
There were more than 626,000 births in the NHS in 2017/18, with around 100,000 neonatal admissions to hospital each year. This report focuses on how
Friday 22 July at 1:30pm via Zoom. Agenda Apologies for absence To receive any apologies for absence. Declarations of interest To declare
Recommendation ID NG101/8 Question What is the adherence to, and satisfaction with, different intervention formats (for example, individual
Recommendation ID IPG765/1 Question Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children
Recommendation ID NG101/10 Question Efectiveness of 26 Gy in 5 fractions over 1 week regimen in people receiving nodal irradiation- What
Recommendation ID NG101/9 Question Effectivness of 26 Gy in 5 fractions over 1 week regimen in people receiving breast construction- What
Recommendation ID NG101/7 Question Strategies to reduce arm and shoulder problems- What is the most effective and cost-effective way of
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)
This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE). It also covers testing for conditions that can make a DVT or PE more likely, such as thrombophilia (a blood clotting disorder) and cancer.
Read NICE's statement on modern slavery and human trafficking
The upcoming editions of BNF and BNFC (scheduled for distribution in October and November 2023) will be the last print editions to be supplied to the NHS in England by NICE.
Afamelanotide for treating erythropoietic protoporphyria (HST27)
Evidence-based recommendations on afamelanotide (Scenesse) for treating erythropoietic protoporphyria in adults.
Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer (TA911)
Evidence-based recommendations on selpercatinib (Retsevmo) for untreated RET fusion-positive advanced non-small-cell lung cancer in adults.
This guideline covers identifying, assessing and managing obesity in children (aged 2 years and over), young people and adults.
Evidence-based recommendations on KardiaMobile for detecting atrial fibrillation.
NICE is unable to make a recommendation on semaglutide (Wegovy) for managing overweight and obesity in young people aged 12 to 17 years because Novo Nordisk did not provide an evidence submission. We will review this decision if the company decides to make a submission.
Show all sections
Sections for TA910
Study NICE and LSE's Executive MSc Healthcare Decision-Making
Study NICE and LSE's Executive MSc Healthcare Decision-Making
Apply to the bursary scheme to find out more about how NICE is focusing on what matters most to the health and care system and delivering useful and usable advice, when and where it is most needed.
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer (TA909)
Evidence-based recommendations on lorlatinib (Lorviqua) for untreated ALK-positive advanced non-small-cell lung cancer in adults.
This guidance evaluates new, innovative diagnostic technologies. It includes all types of measurements and tests that are used to evaluate a patient's
Recommendation ID DG53/1 Question Further research is recommended to determine the impact of MRI fusion biopsy systems compared with cognitive
Recommendation ID DG53/2 Question Further data collection or research is recommended on the impact of implementing MRI fusion biopsy systems
Recommendation ID DG52/3 Question The committee recommends collecting further data on clinical outcomes such as time to healing, and incorrect
Recommendation ID DG52/2 Question The committee recommends collecting further data on the impact of the automated devices on time to treatment
Recommendation ID DG52/1 Question The committee recommends more research on diagnostic accuracy in people with leg ulcers. The following
Help for care home managers and staff to prevent infection
How NICE uses cookies and how you can manage them.
This quality standard covers identifying and supporting adults and young people (aged 10 and over) who may have an alcohol-use disorder and caring for people with alcohol-related health problems, as well as support for their families and carers. It describes high-quality care in priority areas for improvement.
View quality statements for QS11Show all sections
Sections for QS11
- Quality statements
- Quality statement 1: Use of validated alcohol questionnaires
- Quality statement 2: Community support networks and self-help groups
- Quality statement 3: Triage assessment in specialist alcohol services
- Quality statement 4: Acute alcohol withdrawal
- Quality statement 5: Interventions to prevent relapse after unplanned withdrawal from alcohol in hospital
- Update information
- About this quality standard
Evidence-based recommendations on AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images
Doctors have been advised to offer people with signs or symptoms of colorectal cancer a home test to reduce the waiting times for a colonoscopy, NICE has said in draft guidance.
Irreversible electroporation for treating prostate cancer (IPG768)
Evidence-based recommendations on irreversible electroporation for treating prostate cancer. This involves using electrical pulses to destroy the cancer cells.
View recommendations for IPG768Show all sections
Evidence-based recommendations on rimegepant (Vydura) for preventing migraine in adults.
Evidence-based recommendations on olaparib (Lynparza) for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy in adults.
Dr Sam Roberts, chief executive of NICE, celebrates the NHS on its 75th anniversary. She discusses how NICE has supported the NHS with its recent achievements. She also highlights how NICE is evolving; through driving value-based healthcare to support the NHS as it adapts to meet current challenges.